Word

BIOSE

Status

Registered

Status Code

707

Status Date

Friday, January 13, 2023

Serial Number

79182715

Registration Number

5056931

Registration Date

Tuesday, October 11, 2016

Mark Type

4000

Filing Date

Friday, July 3, 2015

Published for Opposition

Tuesday, July 26, 2016

Trademark Owner History

BIOSE INDUSTRIE -
BIOSE - Original Registrant

Classifications

41 [ Arranging and conducting of educational colloquiums, conferences, seminars and events for scientific purposes in the field of microbiota, of probiotics as pharmaceutical preparations, of the probiotics industry, of good practice in the field of microbiota, of probiotics, of changes to regulations relating to probiotics and microbiota ]

5 [ Pharmaceutical products made with the microbiota, namely, bacteria, probiotics and tribiotics for treating gynecological disorders, intestinal disorders, gastroenterological disorders linked to imbalances in the intestinal flora, vaginal flora, dermatological diseases, immune, auto-immune and inflammatory, diseases of the ear, nose and throat, allergies; chemical or biological pharmaceutical preparations for pharmaceutical, medical and sanitary purposes, namely, microbiota, bacteria, probiotics and tribiotics for treating gynecological disorders, intestinal disorders, gastroenterological disorders linked to imbalances in the intestinal flora, vaginal flora, dermatological diseases, immune, auto-immune and inflammatory, diseases of the ear, nose and throat, allergies; sanitary and medical preparations, namely, bacteria for use in the composition of biological pharmaceuticals for treating gynecological disorders, intestinal disorders, gastroenterological disorders linked to imbalances in the intestinal flora, vaginal flora, dermatological diseases, immune, auto-immune and inflammatory, diseases of the ear, nose and throat, allergies; biological or chemical preparations for pharmaceutical, medical use, toilet, namely, probiotics, tribiotics in capsules, capsules and sachets for treating or preventing the gastroenterological disease, gyncological, ear, nose and throat, dermatological, allergic, immune or inflammatory, diseases associated with an imbalance in the vaginal or intestinal flora, flatulence, diarrhea, abdominal pain, spasms, or for improving regulation of intestinal transit; vaginal capsules for treating gynecological diseases; preparations for medical use, namely, antifungals, antimycotics, antiflatulent agents, antidiarrheic agents, antispasmodics, antiinflammatories or antibiotics; disinfectants for hygiene care of patients suffering from gastroenterological diseases, imbalance of the intestinal flora, gynecological diseases, imbalance of the vaginal flora; nutritional supplements, namely, food beverages, bars and meal replacement substances adapted for medical use, dietetic purposes, treating or preventing gynecological disorders, gastroenterological, intestinal disorders linked to imbalances in the intestinal flora, vaginal flora, dermatological diseases, immune, auto-immune and inflammatory, diseases of the ear, nose and throat; nutritional supplements, namely, meal replacement foods, beverages, bars made from a combination of probiotics, minerals and/or vitamins; vitamin preparations, namely, vitamin supplements; medical preparations for slimming; mineral food supplements ]

42 Laboratory services for the provision of scientific analysis and research services, medical, pharmaceutical, pharmacological, bacteriological, chemical and microbiological, design and production of pharmaceutical preparations, probiotics, tribiotics for others; consulting in production of pharmaceutical preparations; quality control; testing in laboratory; services for assessing the efficiency of pharmaceuticals; auditing and auditing pharmaceutical manufacturing processes; packaging design services; kitchen design of preventive quality assurance and quality control relating to the manufacture of pharmaceutical preparations; auditing and testing standards and practices in the field of the manufacture of probiotics, tribiotics, ensure compliance with governmental regulations and industrial practices, practices quality control and quality assurance; conducting pharmaceutical research projects and technical project studies; engineering; provision of information and data relating to medical and scientific research in the field of pharmaceuticals, probiotics, and clinical trials relating to scientific research and development; provision and exchange of knowledge, industrial know-how and data relating to scientific research and development; provision and exchange of information and data exchange between scientists, manufacturers and health authorities relating to pharmaceutical regulatory affairs and the application thereof to probiotics; expertise services and technical advice in the field of scientific research for medical and pharmaceutical purposes, in the field of probiotics; development and maintenance of data banks and databases; extraction and retrieval of information and data mining; managing of working groups bringing together scientists and manufacturers to resolve problems in connection with probiotics; research and drafting of information provided by scientific research in the field of medical research, pharmaceutical, pharmacological in regulatory affairs in the field of probiotics

The wording "BIOSE" has no meaning in a foreign language.

Trademark Events

Oct 31, 2023

Partial Invalidation Processed By The Ib

Sep 23, 2023

Partial Invalidation Of Reg Ext Protection Sent To Ib

Sep 23, 2023

Invalidation Processed

Sep 13, 2023

Partial Invalidation Of Reg Ext Protection Created

Jan 13, 2023

Notice Of Acceptance Of Sec. 71 - E-Mailed

Jan 13, 2023

Registered - Partial Sec 71 Accepted

Jan 10, 2023

Case Assigned To Post Registration Paralegal

Jul 1, 2022

Teas Section 71 Received

Sep 11, 2020

Change Of Owner Received From Ib

Mar 13, 2017

Correction From The Ib Examined, No Action Is Needed

Mar 3, 2017

Final Decision Transaction Processed By Ib

Feb 17, 2017

Correction Transaction Received From Ib

Feb 13, 2017

Final Disposition Notice Sent To Ib

Feb 13, 2017

Final Disposition Processed

Jan 11, 2017

Final Disposition Notice Created, To Be Sent To Ib

Oct 11, 2016

Registered-Principal Register

Jul 26, 2016

Published For Opposition

Jul 6, 2016

Notice Of Publication

Jun 20, 2016

Law Office Publication Review Completed

Jun 16, 2016

Change Of Name/Address Rec'd From Ib

Jun 14, 2016

Approved For Pub - Principal Register

Jun 2, 2016

Teas/Email Correspondence Entered

Jun 2, 2016

Correspondence Received In Law Office

May 27, 2016

Assigned To Lie

May 17, 2016

Teas Response To Office Action Received

Mar 26, 2016

Refusal Processed By Ib

Mar 4, 2016

Non-Final Action Mailed - Refusal Sent To Ib

Mar 4, 2016

Refusal Processed By Mpu

Mar 4, 2016

Non-Final Action (Ib Refusal) Prepared For Review

Mar 3, 2016

Non-Final Action Written

Mar 1, 2016

Application Filing Receipt Mailed

Feb 25, 2016

Assigned To Examiner

Feb 25, 2016

New Application Office Supplied Data Entered

Feb 24, 2016

Limitation From Original Application Entered

Feb 23, 2016

Sn Assigned For Sect 66a Appl From Ib